| 000 | 01878 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515120641.0 | ||
| 264 | 0 | _c20080812 | |
| 008 | 200808s 0 0 eng d | ||
| 022 | _a1521-0103 | ||
| 024 | 7 |
_a10.1124/jpet.108.137208 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMasood, Anbrin | |
| 245 | 0 | 0 |
_aReversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cAug 2008 |
||
| 300 |
_a369-79 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xmetabolism |
| 650 | 0 | 4 |
_aAnxiety _xdrug therapy |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 | _aButhionine Sulfoximine |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCerebral Cortex _xcytology |
| 650 | 0 | 4 |
_aCyclic GMP _xmetabolism |
| 650 | 0 | 4 |
_aCyclic Nucleotide Phosphodiesterases, Type 2 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aLipid Peroxides _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMaze Learning _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred ICR |
| 650 | 0 | 4 |
_aNADPH Oxidases _xbiosynthesis |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 700 | 1 | _aNadeem, Ahmed | |
| 700 | 1 | _aMustafa, S Jamal | |
| 700 | 1 | _aO'Donnell, James M | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 326 _gno. 2 _gp. 369-79 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/jpet.108.137208 _zAvailable from publisher's website |
| 999 |
_c17952700 _d17952700 |
||